DOCSLIB.ORG

Anemia Testing in Population-Based Surveys

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Anemia Testing in Population-Based Surveys Anemia Testing in Population-Based Surveys Anemia Testing in Population-Based Surveys General Information and Guidelines for Country Monitors and Program Managers Almaz Sharman ORC Macro Calverton, Maryland, USA June 2000 This publication was prepared under the auspices of the MEASURE DHS+ project. The MEASURE DHS+ project assists developing countries in the collection and use of data to monitor and evaluate trends in population, health, and nutrition. Funded by the U.S. Agency for International Development (USAID), MEASURE DHS+ is administered by ORC Macro in Calverton, Maryland. The main objectives of the MEASURE DHS+ project are as follows: 1) to provide decisionmakers in survey countries with information that is useful for informed policy choices, 2) to expand the international population and health database, 3) to advance survey methodology, and 4) to develop in participating countries the skills and resources necessary to conduct high-quality demographic and health surveys. Information about the MEASURE DHS+ project can be obtained by contacting ORC Macro, 11785 Beltsville Drive, Suite 300, Calverton, MD 20705 USA (Telephone: 301-572-0200; Fax: 301-572-0999; E-mail: [email protected]; Internet: http://www.measuredhs.com). Recommended citation: Sharman, Almaz. 2000. Anemia testing in population-based surveys: General information and guidelines for country monitors and program managers. Calverton, Maryland USA: ORC Macro. CONTENTS Foreword ...................................................................................................................................................vii PART I GENERAL INFORMATION ON ANEMIA: CAUSES, PREVALENCE, CONTROL AND PREVENTION Chapter 1 Definition, Consequences, Clinical Manifestations and Prevalence of Anemia 1.1 Definition and Consequences of Anemia............................................................................ 3 Definition of Anemia .......................................................................................................... 3 Anemia and Maternal Health.............................................................................................. 3 Effects of Anemia on Mental Performance ........................................................................ 3 Anemia and Resistance to Infections.................................................................................. 4 Effect on Work Capacity .................................................................................................... 4 1.2 Clinical Manifestations of Anemia ..................................................................................... 4 1.3 Prevalence of Anemia in the World.................................................................................... 5 Chapter 2 Physiology of Iron Requirements and Main Causes of Anemia 2.1 Main Causes of Anemia......................................................................................................7 2.2 Physiologic Iron Requirements........................................................................................... 8 Iron Losses in Pregnancy and Lactation ........................................................................... 10 Iron Requirements in Infancy and Childhood................................................................... 11 2.3 Dietary Iron Content and Bioavailability of Iron.............................................................. 11 2.4 Anemia Caused by Deficiency of Folic Acid ................................................................... 13 Increased Demand............................................................................................................. 13 Inadequate Intake.............................................................................................................. 13 Impaired Absorption......................................................................................................... 14 2.5 Parasite Infestations and Anemia...................................................................................... 14 Hookworm Infestation ...................................................................................................... 14 Whipworm Infestation ...................................................................................................... 14 Schistosomiasis................................................................................................................. 14 2.6 Anemia Caused by Malaria............................................................................................... 15 Epidemiology of Malaria .................................................................................................. 15 Pathogenesis of Malarial Anemia ..................................................................................... 15 iii Chapter 3 Anemia Control and Prevention 3.1 Magnitude of the Problem and Importance of Anemia Control and Prevention .............. 17 Global Burden of Anemia and Effectiveness of Anemia Control and Prevention............ 17 Integrated Anemia Control and Prevention Strategy ........................................................ 17 3.2 Dietary Improvement........................................................................................................ 18 3.3 Iron Supplementation........................................................................................................ 18 Iron Supplementation in Pregnancy.................................................................................. 18 Iron Supplementation During Infancy and Early Childhood............................................ 19 Iron Supplementation to Other Population Groups........................................................... 20 Limitations of Iron Supplementation Programs................................................................ 21 3.5 Iron Fortification............................................................................................................... 21 Overall Approach to Anemia Control and Prevention...................................................... 22 3.6 Management and Treatment of Patients with Anemia...................................................... 22 Management of Patients with Anemia.............................................................................. 22 Protocols for Drug Therapy of Patients with Severe Anemia........................................... 23 PART II METHODOLOGY, TRAINING GUIDELINES, AND FIELD IMPLEMENTATION OF ANEMIA SURVEYS Chapter 4 Methods of Anemia Testing 4.1 Modern Methods of Anemia Testing................................................................................ 27 Modern Methods of Anemia Testing................................................................................ 27 HemoCue System ............................................................................................................. 28 4.2 Hemoglobin Cutoff Points................................................................................................ 28 Chapter 5 Methodological Issues of Population-Based Anemia Testing 5.1 Individual Variability of Capillary Hemoglobin Testing.................................................. 33 Physiologic Variation of Capillary Blood Sampling ........................................................ 33 Variability Caused by Improper Capillary Sampling ....................................................... 34 5.2 Capillary Blood Testing Versus Venous Blood Testing................................................... 34 5.3 Determining Iron Status.................................................................................................... 34 Clinical Approach............................................................................................................. 35 Population-Based Approach ............................................................................................. 36 iv Chapter 6 Anemia Training Guidelines 6.1 Personnel Requirements ................................................................................................... 39 6.2 Training Schedule............................................................................................................. 40 Day One ............................................................................................................................ 40 Day Two ........................................................................................................................... 40 Day Three ......................................................................................................................... 41 Day Four ........................................................................................................................... 41 6.3 Quality Assurance............................................................................................................. 41 Chapter 7 Procedures for Implementing an Anemia Survey 7.1 Planning a Population-based Anemia Survey................................................................... 43 7.2 Sampling Issues ................................................................................................................ 44 7.3 Field Supervision .............................................................................................................. 44 Field Checklist .................................................................................................................. 45 7.4 Referral System................................................................................................................
Load more

Recommended publications
  • Reproductive, Maternal and Child Health in Eastern Europe and Eurasia: a Comparative Report
    REPRODUCTIVE, MATERNAL AND CHILD HEALTH IN EASTERN EUROPE AND EURASIA: A COMPARATIVE REPORT Division of Reproductive Health ORC MACRO DHS Centers for Disease Control and Prevention 11785 Beltsville Drive Atlanta, GA 30333 Calverton, MD 20705 April, 2003 PRINTED BY: U. S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Atlanta, GA 30333 USA This comparative report on data from surveys conducted in Eastern Europe and Eurasia is funded by the United States Agency for International Development (USAID) PASA DPE-3038-X-HC-1015-00 with the Division of Reproductive Health of the Centers for Disease Control and Prevention and USAID Contract No. HRN-C-00-97-0019-00 with ORC Macro. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID. Additional information about this report may be obtained from: Division of Reproductive Health, Centers for Disease Control and Prevention (DRH/CDC), Mailstop K-23, 4770 Buford Highway, NE, Atlanta, GA 30341, 3724, USA. Fax (770) 488-6242; Tel (770) 488-6200, or from ORC Macro, 11785 Beltsville Drive, Calverton, MD 20705, USA. Fax (301) 572-0999, Tel (301) 572-0200. Suggested citation: Centers for Disease Control and Prevention and ORC Macro. 2003. Reproductive, Maternal and Child Health in Eastern Europe and Eurasia: A Comparative Report. Atlanta, GA (USA) and Calverton, MD (USA). TABLE OF CONTENTS Page ACKNOWLEDGEMENTS ................................................................................................................i
    [Show full text]
  • PERSONALIZED MEDICINE and GLOBAL HEALTH» Theme: Paving the Way of Personalized Medicine in Kazakhstan in the Era of Innovative Technologies
    N A T I O N A L LABORATORY ASTANA 3rd INTERNATIONAL CONFERENCE «PERSONALIZED MEDICINE AND GLOBAL HEALTH» Theme: Paving the way of Personalized medicine in Kazakhstan in the era of innovative technologies September 15, 2017 Astana, Republic of Kazakhstan ЕРМА Kazakhstan Association PARTNERS: Eurasian Personalized Medicine Association of Human Microbiomе Researchers SPONSORS SPONSORS SPONSORS SPONSORS SPONSORS SPONSORS EDITORIAL BOARD Ilesanmi Adesida Zhaxybay Zhumadilov Ainur Akilzhanova Ulykbek Kairov Ainur Akhmetova Ulan Kozhamkulov Saule Rakhimova Dauren Yerezhepov Zhannur Abilova Askhat Molkenov Maxat Zhabagin Almagul Kushugulova Samat Kozhakhmetov Zhazira Bukina Dear Friends and Colleagues, It is my pleasure and honor to welcome you to the 3rd International Scientific Conference on “Personalized Medicine & Global Health”. Nazarbayev University in collaboration with NLA continues its tradition of hosting the international scientific community in Astana, Kazakhstan. The Conferences held during the previous years, brought together exceptional researchers and scientists to discuss the emerging trends in personalized medicine. I am excited that this 3rd International Conference, will among others, showcase research initiatives undertaken by Kazakhstan’s younger generation of scientists. The conference is structured around plenary sessions, keynote lectures, and poster presentations, thus providing a multidisciplinary forum for researchers, clinical doctors, policy makers, and representatives of healthcare systems. I welcome you to Nazarbayev
    [Show full text]
  • Measure Results Package Evaluation and Pre
    MEASURE RESULTS PACKAGE EVALUATION AND PRE-DESIGN STUDY MAY 2001 Judith R. Seltzer James C. Knowles Anibal Faúndes Roger W. Rochat Anne-Marie Foltz Mark H. Spohr Submitted by: LTG Associates, Inc. TvT Associates, Inc. Submitted to: The United States Agency for International Development Under USAID Contract No. HRN–C–00–00–00007–00 This document is available in printed or online versions (POPTECH Publication Number 2001–019–004). To review and/or obtain a document online, see the POPTECH web site at www.poptechproject.com. Documents are also available through the Development Experience Clearinghouse (www.dec.org). Printed copies and additional information about this and other POPTECH publications may be obtained from: The Population Technical Assistance Project 1101 Vermont Avenue, NW, Suite 900 Washington, DC 20005 Telephone: (202) 898-9040 Fax: (202) 898-9057 [email protected] MEASURE Results Package: Evaluation and Pre-Design Study was made possible through support provided by the United States Agency for International Development (USAID) under the terms of Contract Number HRN–C–00– 00–00007–00, POPTECH Assignment Number 2001–019. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID. ACKNOWLEDGMENTS The evaluation and pre-design team would like to thank USAID staff for its work in designing the scope of work and in briefing the team. In particular, we thank Krista Stewart, CTO for the MEASURE Results Package (RP), and the technical advisors for MEASURE: Joanne Jeffers, Norma Wilson, Jacob Adetunji, Michal Avni, Sara Pacque-Margolis, and Naomi Blumberg. The team also appreciated the considerable effort made by the MEASURE partners in preparing briefings and providing documentation of the work of the five component projects under the RP.
    [Show full text]
  • Almaz Sharman, MD, Phd THIRTY YEARS EXPERIENCE in HEALTH CARE MANAGEMENT and BIOMEDICAL RESEARCH
    Almaz Sharman, MD, PhD THIRTY YEARS EXPERIENCE IN HEALTH CARE MANAGEMENT AND BIOMEDICAL RESEARCH EMPLOYMENT SUMMARY Nazarbayev University Deputy Chairman of 2010-Present Astana, Kazakhstan Executive Board Chairman of the Board Center for Life Sciences National Medical Holding Chief Executive Officer 2008 - 2010 Astana, Kazakhstan Member of the Board 2010 - Present Medtronic Inc. Founder of Kazakhstan 2006 - 2008 Almaty, Kazakhstan Country Office US Agency for International Development Country Office Coordinator 2004 - 2006 Regional Mission for Central Asia for Kazakhstan Almaty, Kazakhstan Infectious Disease Advisor 2001 - 2004 The Johns Hopkins University, Associate at Bloomberg 1997 - 2004 Baltimore, MD, USA School of Public Health ICF Macro, Demographic and Health Surveys Health Coordinator 1994 - 2001 Division, Calverton, MD, USA University of Alabama at Birmingham, Research Fellow 1991 - 1994 Immunobiology Vaccine Center, USA Bogomolets Medical Institute, Kiev, Ukraine Visiting Scientist 1991 Institute of Physiology, Almaty, Kazakhstan Research Associate 1988 - 1991 Institute of Immunology, Moscow, Russia Visiting Scientist 1983 - 1988 Institute of Regional Diseases Intern and Resident 1982 -1985 Ministry of Health of Kazakhstan 1 EDUCATION Bogomolets Medical Institute, Kiev, Ukraine Dr. Sc. Internal Medicine/Immunology 1991 Institute of Immunology, Moscow, Russia PhD Internal Medicine/Immunology 1985 Asfendiyarov National Medical University, M.D. Internal Medicine and 1982 Almaty, Kazakhstan Public Health LEADERSHIP TRAININGS Leadership Development for Physicians in Academic Health Centers. Harvard University, Boston, MA, USA. October 14–26, 2012. Two weeks of intensive and systematic study of some of the critical leadership and management issues which face physicians in administrative positions and academic health centers. Executive Development Seminar: Leading Change. Federal Executive Institute, Center for Executive Leadership, Charlottesville, VA, USA, February 8 – 14, 2004.
    [Show full text]
  • Newsletter Issue 16, October 2017
    RESEARCH Office of the Provost (Research Division) Newsletter Issue 16, October 2017 NEWSLETTER HIGHLIGHTS Dear colleagues and students! You are reading the 16th edition of our Research Newsletter. We would like to announce that since that edition all the new releases will be under the Office of the Provost (Research Division) because Research Services Office was merged with the Office of the Provost without any major structural changes in the job responsibilities of the Office. In this newsletter, you’ll find out about what’s been happening in the recent month in research life of the University. You will also read the interview with our Provost Ilesanmi Adesida in the “In the Spotlight” section. The newsletter also contains information of interest to our faculty members in the sections “Grants and Competitions”, “Useful information” and “Congratulations” and “Announcements”. We appreciate you taking the time to read our newsletter. If you have any questions, suggestions, or concerns, please address them to the Research Division of the Office of the Provost ([email protected]). We hope to hear from you soon, and we welcome your feedback! Sincerely yours, Office of the Provost (Research Division) 2 CONTENTS IN THE SPOTLIGHT Interview with the NU Provost Prof. Ilesanmi Adesida………………………………………………………………… 5 RESEARCH NEWS Research news from National Laboratory Astana……………………………………………………………………… 10 Research news from the School of Humanities and Social Sciences………………………………………… 15 Keynote speech and workshop at College of Engineering, Trivandrum
    [Show full text]
  • Anemia Testing in Population-Based Surveys
    Anemia Testing in Population-Based Surveys Anemia Testing in Population-Based Surveys General Information and Guidelines for Country Monitors and Program Managers Almaz Sharman ORC Macro Calverton, Maryland, USA June 2000 This publication was prepared under the auspices of the MEASURE DHS+ project. The MEASURE DHS+ project assists developing countries in the collection and use of data to monitor and evaluate trends in population, health, and nutrition. Funded by the U.S. Agency for International Development (USAID), MEASURE DHS+ is administered by ORC Macro in Calverton, Maryland. The main objectives of the MEASURE DHS+ project are as follows: 1) to provide decisionmakers in survey countries with information that is useful for informed policy choices, 2) to expand the international population and health database, 3) to advance survey methodology, and 4) to develop in participating countries the skills and resources necessary to conduct high-quality demographic and health surveys. Information about the MEASURE DHS+ project can be obtained by contacting ORC Macro, 11785 Beltsville Drive, Suite 300, Calverton, MD 20705 USA (Telephone: 301-572-0200; Fax: 301-572-0999; E-mail: [email protected]; Internet: http://www.measuredhs.com). Recommended citation: Sharman, Almaz. 2000. Anemia testing in population-based surveys: General information and guidelines for country monitors and program managers. Calverton, Maryland USA: ORC Macro. CONTENTS Foreword ...................................................................................................................................................vii
    [Show full text]
  • Better Health for Europe: More Equitable and Sustainable
    Better Health for Europe: more equitable and sustainable S SDG RK 13 F WO E O M 0 M H 202 RA LT G EA O H R P L A R E N E G Transformational Reflections 2010–2020 Better Health for Europe: more equitable and sustainable S SDG RK 13 F WO E O M 0 M H 202 RA LT G EA O H R P L A R E N E G Transformational Reflections 2010–2020 September 2019 Abstract Better Health for Europe: more equitable and sustainable, tells the story of how people working for WHO in the European Region have sought to make a reality of this goal over the last ten years. Zsuzsanna Jakab, WHO Regional Director for Europe from 2010 until 2020, narrates the story on behalf of all staff and describes the vision, strategic thinking and processes followed, as well as the impact achieved. Political leaders, public health managers and health practitioners and advocates from across the WHO European Region and beyond were invited to reflect upon the relevance and utility of the work of the Regional Office. Extracts from interviews with these ‘witnesses’ are presented throughout the book to enrich the narrative. This book is divided into three parts. Part I – Better Health for Europe: the seven strategic action priorities, presents the systematic process the Regional Office has followed in developing the policy frameworks, evidence base, capacities, relationships, partnerships, networks and skills needed to transform and enhance action for better, more equitable and sustainable health and well-being in Europe and beyond.
    [Show full text]
  • Kazakhstan Demographic and Health Survey 1999 [FR111]
    World Summit for Children Indicators: Kazakhstan 1999 __________________________________________________________________________________________________ Value __________________________________________________________________________________________________ BASIC INDICATORS __________________________________________________________________________________________________ Childhood mortality Infant mortality rate 61.9 per 1,000 Under-five mortality rate 71.4 per 1,000 Maternal mortality Maternal mortality ratio 62.5 per 100,0001 Childhood undernutrition Percent stunted (of children under 5 years) 9.7 Percent wasted (of children under 5 years) 1.8 Percent underweight (of children under 5 years) 4.2 Clean water supply Percent of households within 15 minutes of a safe water supply2 83.6 Sanitary excreta disposal Percent of households with flush toilets 47.2 Basic education Percent of women 15-49 with completed primary education 99.3 Percent of men 15-49 with completed primary education 99.1 Percent of girls 6-12 attending school 81.4 Percent of boys 6-12 attending school 80.3 Percent of women 15-49 who are literate 99.8 Children in especially Percent of children who are orphans (both parents dead) 0.2 difficult situations Percent of children who do not live with their natural mother 6.2 Percent of children who live in single adult households 5.9 __________________________________________________________________________________________________ SUPPORTING INDICATORS __________________________________________________________________________________________________
    [Show full text]
  • President Urges Country to Use “Window Nazarbayev of Opportunity” of Next 15 Years Holds Key by George D
    -26°C / -30°C WEDNESDAY, JANUARY 29, 2014 No 2 (45) www.astanatimes.com President Urges Country to Use “Window Nazarbayev of Opportunity” of Next 15 Years Holds Key By George D. Gleboff cluding agglomerations (Astana, Almaty, Shymkent and Aktobe), Meetings in ASTANA – In his widely antici- transportation and energy; pro- pated State-of-the-Nation address moting small and medium-sized on Jan. 17, President Nursultan businesses as the backbone of the Davos Nazarbayev outlined in detail his economy; pursuing a host of pro- By Aveya Bremen vision of how Kazakhstan, a coun- grammes in education, healthcare try only 22 years old, could be- and social protection to develop Kazakhstan’s President Nursul- come one of the world’s 30 most human potential further and im- tan Nazarbayev participated in the developed and competitive nations proving the work of public institu- World Economic Forum in Davos, by 2050. To catch up with the de- tions. Switzerland on Jan. 22-23 and called veloped world, he said, Kazakh- Regarding innovative industri- the gathering a useful platform for stan will need to run twice as fast. alisation, Nazarbayev stressed that the exchange of opinions on global Addressing the 1,200 officials, mining will need to be developed, economic issues and global develop- including members of both houses as subsoil use provides the coun- ment. of Parliament, ministers and se- try with a natural competitive ad- “The Davos forum is a place lected guests from social, politi- vantage, but that new approaches where you have an intense sched- cal, economic and cultural circles, to managing, producing and pro- ule of meetings, as it gathers a large who gathered at the Palace of In- cessing hydrocarbons need to be number of heads of state, leaders dependence for the speech, Naz- developed.
    [Show full text]
  • United Nations E
    UNITED NATIONS E Distr. Economic and GENERAL Social Council ECE/TCU/CONF.1/2005/1 25 July 2005 ENGLISH Original: ENGLISH and RUSSIAN only ECONOMIC COMMISSION FOR EUROPE ECONOMIC AND SOCIAL COMMISSION FOR ASIA AND THE PACIFIC International conference on strengthening sub-regional economic cooperation in Central Asia and the future role of SPECA Astana, Kazakhstan, 25-27 May 2005 FINAL REPORT Introduction Strengthening sub-regional economic cooperation is an important condition for promoting prosperity, stability and security in Central Asia and the broader region. It will also help the countries of Central Asia to achieve the internationally agreed development goals contained in the Millennium Declaration and facilitate their progress towards sustainable development. In early 2004, the United Nations Secretary-General launched an initiative aimed at reinvigorating the UN Special Programme for the Economies of Central Asia (SPECA). The Programme was established in 1998 with a view to strengthening sub-regional cooperation in Central Asia and its integration into the world economy. Currently it involves Azerbaijan, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan and is jointly supported by UNECE and UNESCAP. The secretariats of the two UN Regional Commissions, in consultation with interested countries and other partners, developed a set of proposals for improving the institutional set-up, working methods and funding of SPECA, as well for significantly broadening the scope of cooperation within its framework. In September 2004, the Government of Kazakhstan proposed to convene in Astana in May 2005 an international conference on SPECA with broad participation of countries, international organizations and financial institutions and other partners, at which issues related to the strengthening of SPECA would be placed in a broader context of sub-regional cooperation in Central Asia as well as more general efforts of the international community in the region in support of this objective.
    [Show full text]
  • Syrian Peace Talks in Astana End with Support for Ceasefire, Further
    -2° / -16°C WEDNESDAY, JANUARY 25, 2017 No 2 (116) www.astanatimes.com Syrian Peace Talks in Astana End with Support Kazakh President, for Ceasefire, Further Talks in Geneva Special Panel Mull Major Political Reforms The head of state highlighted the By Yerbolat Uatkhanov reduction of the powers originally referred strictly to the competence ASTANA – Kazakh President of the Kazakhstan President. Nursultan Nazarbayev took Jan. “For example, such authority 24 part in the meeting of a working as programme approval, issues group on the redistribution of pow- of personnel changes in the gov- ers between government branches. ernment, creation of new gov- He stated that the redistribution erning bodies can be transferred of powers between the branches to the competence of the gov- of government is a consistent and ernment and the Parliament,” he logical step in the development of said. the state. The Kazakh President empha- “Implementation of one of the sised the need to strengthen the five institutional reforms that I role of Parliament in the public ad- proposed, includes giving the ministration system. government additional executive “In our conditions, the govern- powers in the economic field. The ment is formed by the winning President will still be responsible party or faction. Thus, the role of for main issues in defence, foreign Parliament has to be revised in re- policy, governance, protection lation to the government on many of the Constitution and effective issues,” President Nazarbayev work between branches of govern- said. was a unique opportunity,” said de ment,” President Nazarbayev said. Continued on Page A2 By Zhazira Dyussembekova Mistura at a press conference after the talks, adding he will present ASTANA – Three guarantor the results at the UN in New York states of the recent efforts to end next week.
    [Show full text]
  • Strengthening the Response to Noncommunicable Diseases in Central Asia and Eastern Europe
    Strengthening the response to noncommunicable diseases in central Asia and eastern Europe 4 October 2012, Bad Gastein, Austria Report of the meeting Strengthening the response to noncommunicable diseases in central Asia and eastern Europe Keywords CHRONIC DISEASE – PREVENTION AND CONTROL DELIVERY OF HEALTH CARE HEALTH MANAGEMENT AND PLANNING HEALTH SYSTEMS PLANS – ORGANIZATION AND ADMINISTRATION NATIONAL HEALTH PROGRAMS PRIMARY HEALTH CARE Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Scherfigsvej 8 DK-2100 Copenhagen Ø, Denmark Alternatively, complete an online request form for documentation, health information, or for permission to quote or translate, on the Regional Office web site (http://www.euro.who.int/pubrequest). © World Health Organization 2012 All rights reserved. The Regional Office for Europe of the World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
    [Show full text]